Abstract
During the last 2 years, our laboratory has worked on the elucidation of the molecular basis of capacitative calcium entry (CCE) into cells. Specifically, we tested the hypothesis that CCE channels are formed of subunits encoded in genes related to the Drosophila trp gene. The first step in this pursuit was to search for mammalian trp genes. We found not one but six mammalian genes and cloned several of their cDNAs, some in their full length. As assayed in mammalian cells, overexpression of some mammalian Trps increases CCE, while expression of partial trp cDNAs in antisense orientation can interfere with endogenous CCE. These findings provided a firm connection between CCE and mammalian Trps. This article reviews the known forms of CCE and highlights unanswered questions in our understanding of intracellular Ca2+ homeostasis and the physiological roles of CCE.
Keywords: calcium, cell signaling, hormone action, ion channels
The two primary second messengers mediating rapid responses of cells to hormones, autacoids, and neurotransmitters are cyclic nucleotides and Ca2+. Cyclic nucleotides act, for the most part, by activating protein kinases. The actions of Ca2+ are more complex, in that this cation acts in two ways: directly, by binding to effector proteins, and indirectly, by first binding to regulatory proteins such as calmodulin, troponin C, and recoverin, which in turn associate and modulate effector proteins. Effector proteins regulated in these manners by Ca2+ include not only protein kinases and protein phosphatases but also phospholipases and adenylyl cyclases, which are signaling enzymes in their own right, and an array of proteins involved in cellular responses that range from muscle contraction to glycogenolysis, endo-, exo-, and neurosecretion, cell differentiation, and programmed cell death. A common mechanism used by hormones and growth factors to signal through cytosolic Ca2+ ([Ca2+]i) is activation of a rather complex reaction cascade that begins with stimulation of phosphoinositide-specific phospholipase C (PLC) enzymes, PLCβ and PLCγ, and is followed sequentially by formation of diacylglycerol plus inositol 1,4,5-trisphosphate (IP3), liberation of Ca2+ from intracellular stores, and finally, entry of Ca2+ from the external milieu. Table 1 lists examples of extracellular signals that activate cellular PLCs and use changes in [Ca2+]i as part of their signaling mechanism.
Table 1.
Ligand | Receptor |
---|---|
Due to activation of PLCβ enzymes | |
Mediated by Gi-type G proteins (pertussis toxin-sensitive) | |
FMLP | FMLP |
Interleukin 8 | IL-8 |
Mediated by Gq-type G proteins (pertussis toxin-insensitive) | |
Epinephrine | α1-Adrenergic |
Acetylcholine | M1, M3, M5 |
Serotonin (5-HT) | 5-HT2a, 2c |
Histamine | H1 |
ATP | Pu, Py |
Arg-vasopressin | V1a, V1b |
Oxytocin | OT |
Angiotensin II | AT1 |
Bradykinin | BK2 |
Thromboxane | TP |
Prostaglandin F2α | FP |
Endothelin | ET-1, ET-2 |
Colecystokinin | CCK-A |
Gastrin | CCK-B |
Gastrin-release peptide (bombesin) | GRP |
Thyrotropin releasing hormone | TRH |
Gonadotropin releasing hormone | GnRH |
Mediated by either Gi- or Gq-type G proteins | |
Thrombin | Thrombin |
Platelet activating factor | PAF |
Due to activation of PLCγ via tyrosine phosphorylation | |
Antigen | T-cell receptor |
B-cell receptor | |
Epidermal growth factor | EGF |
The basic mechanisms used to signal through [Ca2+]i are determined by the fact that the resting level of cytosolic Ca2+ is very low, in the neighborhood of 100 nM, while that in intracellular stores and in the surrounding extracellular milieu is in the neighborhood of 2 mM, that is, ≈10,000-fold higher. As a result, [Ca2+]i is set by the balance of two opposing forces. One is passive influx into the cytoplasm. It is driven by the electrochemical gradient and causes cytosolic [Ca2+]i to rise without expenditure of energy. This influx is carefully controlled both at the level of the plasma membrane and at the level of the membranes, which delimit the internal storage compartment. Entry of Ca2+ from the extracellular space occurs through three classes of Ca2+ permeable gates: voltage-dependent Ca2+ channels, ligand-gated Ca2+-permeable cation channels, and the so-called capacitative calcium entry (CCE) channels. While voltage-dependent Ca2+ channels and ligand-gated cation channels are expressed in selected sets of cells (neurons, myocytes, and endocrine cells; for reviews see refs. 1–3), CCE channels are ubiquitous (see ref. 4). Entry of Ca2+ from internal stores into the cytoplasm occurs through two classes of Ca2+-release channels, the IP3 receptors and the ryanodine receptors, which, depending on the tissue, may coexist (reviewed in ref. 5). Functional and molecular diversity and/or distinguishing pharmacological properties characterize all three types of Ca2+ entry pathways. The second force opposes the first and is the active extrusion of Ca2+ from the cytoplasmic compartment against the electrochemical gradient, either into the stores or out of the cell. This process requires expenditure of metabolic energy. Pumping into the internal stores is mediated by sarcoplasmic endoplasmic reticulum Ca-ATPases, while extrusion from the cell is mediated by plasma membrane Ca-ATPases. This article deals with the molecular nature and regulation of CCE from the extracellular space stimulated by signals that activate phospholipases. It is not a comprehensive review; rather, it concentrates on aspects that have caught our attention during the last 2 years and some of the initial results from our investigations into CCE and its role in the regulation of [Ca2+]i.
Studies with the fluorescent Ca2+ indicator dye Fura2 on the effect of stimulating PLC on [Ca2+]i have revealed a now well-established response pattern: [Ca2+]i shows an initial rise to a peak level, which, in the continued presence of receptor ligand and extracellular Ca2+, decays to a plateau level that is maintained for as long as the cell is exposed to the stimulus. Fig. 1 shows typical temporal [Ca2+]i response pattern of cultured human embryonic kidney HEK 293 cells induced by ATP and carbachol (CCh), which bind to receptors that are coupled by the Gq class of G proteins and activate β-type PLCs (7, 8), and by epidermal growth factor, which exerts its actions through a typical tyrosine kinase receptor, which, among other effects, stimulates γ-type PLCs (9, 10). In each case, [Ca2+]i rises to a peak level that immediately begins to drop to a lower level that has been termed sustained phase of elevated [Ca2+]i. The difference between the starting and the sustained levels of [Ca2+]i varies with the stimulus and with the cell type and lasts for as long as agonist is present. In the example of Fig. 1, this difference is best seen after stimulation of the muscarinic receptor, but would be clearly apparent if [Ca2+]i would have been followed for longer times after addition of either epidermal growth factor or ATP. As seen with CCh, the sustained phase of the transient is agonist-dependent, as illustrated by the fall to basal levels upon washout of CCh. The example also illustrates that response times after agonist or growth factor vary. With G protein-coupled responses, it is fast, while with tyrosine kinase-coupled systems, it is considerably slower, presumably because signaling through tyrosine phosphorylation is slower than signaling through G proteins.
The experiment in Fig. 1 was carried out in the presence of extracellular Ca2+. In the experiment of Fig. 2, the agonist was added in the absence of extracellular Ca2+, and Ca2+ was added subsequently to illustrate activation of the CCE pathway. In the absence of extracellular Ca2+, the initial increase in [Ca2+]i is followed by return to the basal level of [Ca2+]i, the sustained phase of increased [Ca2+]i being absent. Addition of Ca2+ to the extracellular medium after [Ca2+]i has returned to its resting value leads to an increase in [Ca2+]i, due to activation of the CCE pathway. We term the channels that mediate CCE “CCE channels.”
A striking aspect of CCE channels is that most share the property of being activated in response to store depletion. Due to this, they have also been called store-operated channels. That store depletion is an activating signal for CCE channels was best inferred from the fact that Ca2+ influx into cells was found to be stimulated when depletion was caused secondary to inhibition of sarcoplasmic endoplasmic reticulum Ca-ATPase pumps, as seen with the tumor promoter thapsigargin or the antioxidant t-butylhydroquinone (refs. 11 and 12; reviewed in ref. 13). Activation by store depletion without involvement of an agonist was shown independently in patch clamp experiments in which the patch pipette was loaded with the Ca2+ chelator bis(2-aminophenoxy)ethane-N,N,N′,N′-tetra-acetate (BAPTA) acting as a sink for Ca2+ leaking from the stores. In macrophages and lymphocytes, this maneuver leads to the development of a highly selective inward Ca2+ current, ICRAC, which stands for calcium release-activated calcium current (14–16). Attempts to characterize the single channel conductance of the CCE channel responsible for ICRAC have failed, setting the upper limit at <0.2 pS—i.e., at an ≈100-fold lower value than the single channel conductance of a classical voltage-activated calcium channel. Store depletion-activated CCE in COS cells is seen in Fig. 4C.
We define CCE broadly as calcium entry activated by hormones, autacoids, and growth factors, which is apparent upon Ca2+ addition to a cell that has been stimulated in the absence of extracellular Ca2+. Empirically, CCE has been found to be activated secondarily to application of stimuli that cause IP3-induced store depletion, but store depletion is not always a requisite for CCE. By this definition, ICRAC is a form of CCE. Store depletion-independent activation of CCE channels was described by Fasolato et al. (17), also in macrophages. In their experiments, compound 48/80, which stimulates macrophage PLC via a Gi protein (18), stimulated CCE channels under conditions in which store depletion was blocked with heparin. Fluctuation analysis showed this type of CCE channels to have a single channel conductance of ≈50 pS. Since the 50-pS channels did not show up in the fluctuation analysis of store depletion-activated CCE (ICRAC), it must be agonist-activated and store depletion-insensitive. Macrophage agonist-activated CCE differs from macrophage store depletion-activated CCE, not only in the mechanism of activation, but also in that it is a nonselective Ca2+-permeable cation channel instead of a highly Ca2+-selective ion channel. Another type of CCE channel, with properties intermediate between those of the two types of macrophage channels, was described by Lückhoff and Clapham (19) in A431 cells. In these cells, store depletion activates a 16-pS Ca2+-permeable nonselective cation channel. Another form of Ca2+ entry that may or may not be related to classical CCE was described by Ufret-Vicenti et al. (20), who found that pretreatment of cells with thapsigargin may lead to slow development of a caffeine-stimulated Ca2+ influx. The term noncapacitative calcium entry has been used to describe Ca2+ entry that is stimulated by low levels of agonists, induces oscillatory behavior in cells, can be mimicked by arachidonic acid, and does not cause appreciable store depletion (e.g., ref. 21). Numerous studies have now documented the existence of more than one type of Ca2+ entry in response to stimulation of cells by PLC-activating agonists (reviewed in ref. 4; e.g., refs. 22–26). The very different conditions under which Ca2+ entry can be elicited and its different characteristics has led to the conclusion that CCE channels must be complex and heterogeneous in molecular makeup, in mechanism of activation, and in terms of their ion selectivity.
Key questions about CCE channels include: molecular makeup, their mechanism(s) of activation and regulation, and, since under physiologic conditions their activation is preceded by IP3-induced increases in [Ca2+]i, their role in Ca2+ signaling and in modulation of cellular Ca2+ oscillations. Oscillations are a highly variable phenomenon, which has been observed in many nonexcitable cells under conditions where CCE has been activated. In their sustained (continuing) form, they appear to depend on CCE—i.e., on external Ca2+ (27), and the type and abundance of the receptor through which the cells are stimulated (M.J., X.Z., and L.B., unpublished work). In Fig. 1, for example, stimulation of HEK cells by ATP, but not CCh or epidermal growth factor, leads to oscillatory changes in [Ca2+]i. Fundamental to the answers of all these question is the answer to the first: the molecular identity of CCE channels. Experiments from our and other laboratories indicate that CCE channels are made up of subunits encoded in trp genes.
Trps as Elementary CCE Channel Subunits
Role in Invertebrate Photoreceptor Cells.
In contrast to vertebrate visual signal transduction, which leads to activation of a cGMP-specific phosphodiesterase, the target of the G protein activated by light-activated rhodopsin in invertebrates is a β-type PLC, NorpA (28–30). Different also from vertebrate photosignaling is that the electrical response of the invertebrate photoreceptor cells instead of causing membrane hyperpolarization causes membrane depolarization. Accordingly, electroretinograms of compound eyes exposed to a continuous light pulse show a typical light-induced receptor potential with an initial peak followed by a sustained phase that lasts for as long as the eye is subjected to stimulating light. Alterations in electroretinograms of Drosophila eyes were used as a screen to characterize mutants in the photosignaling cascade. Consistent with a mediatory role for PLC, a no receptor potential mutant, NorpA, was found to encode a PLC. NorpA mutants are blind and their eyes lack PLC activity. Minke and colleagues focused on a mutant that has a transient receptor potential, trp (31). These mutants develop a fast depolarizing response but lack the sustained phase of the receptor potential. Hardie and Minke (32) characterized the function of the missing gene as a light-activated Ca2+-permeable channel.
The trp gene was cloned by Montell and Rubin (33) and shown to encode a protein with eight hydrophobic segments that could potentially form transmembrane segments. Independent research in Australia identified and cloned a calmodulin binding protein from Drosophila heads and found it to be a structural homologue of trp, trp-like (trpl; ref. 34). These authors noted that some of the hydrophobic segments of trp and trpl were homologous to transmembrane segments of voltage-dependent Ca2+ and Na+ channels, with the exception that the putative S4 of trp and trpl lacked the positive amino acids responsible for the voltage-sensing function of voltage-dependent ion channels. In 1993, Hardie and Minke (35) formally raised the question of whether the Trp and Trpl proteins might be functional homologues of CCE channels. More recently, Zuker and coworkers (36) showed that a double trp–trpl mutant not only lacks the sustained phase of the electroretinogram, but exhibits no electrical response whatsoever. They concluded that the light-induced depolarization of the invertebrate photoreceptor cell is due to the combined activation of trp- and trpl-encoded channel proteins. Prior studies had shown that the initial depolarizing response is independent of and precedes store depletion (37).
Trp Proteins and CCE in Vertebrate Cells.
Two lines of research have now established that trp genes encode CCE-type channels. The first, developed by Schilling and coworkers (38, 39), showed that when it is expressed in insect Sf9 cells, Drosophila Trp causes appearance of a store depletion-activated Ca2+-selective conductance, while Trpl causes the appearance of a Ca2+-permeable, store depletion-insensitive, rather nonselective cation conductance that tends to activate spontaneously and appears to respond to IP3. Although neither the conductance induced by Trp nor that induced upon expression of Trpl resembled in their ion selectivity the endogenous agonist-activated CCE channel of a nonphotoreceptor insect cell, the results suggested strongly that Trp-related proteins might make up CCE channels.
The second line of research dealt with the search for trp-related genes and investigation of their role in CCE in vertebrates. We, as well as others, indeed found such vertebrate homologues in expressed sequence tag data bases, which led to the molecular cloning of the full-length cDNA encoding human Trp1 (hTrp1; also TRPC1) and a splice variant lacking 34 amino acids in its N-terminal segment (hTrp1Δ34; refs. 40 and 41). Additional searches, both by PCR and of expressed sequence tag data bases, uncovered the existence of six nonallelic trp-related genes in the mouse genome (6), of which four (genes 1, 3, 4, and 6) have also been identified in human mRNA samples. As shown by the phylogenetic analysis of the known Trp proteins, Trp3 and Trp6 and Trp4 and Trp5 are very closely related to each other, reducing vertebrate Trps to four main subfamilies, subfamilies 1–4, where types 3 and 6 belong to the Trp3 class, while types 4 and 5 belong to the Trp4 class of Trps (ref. 6; Fig. 3).
Two lines of experimental evidence connect mammalian Trp proteins to mammalian CCE channels. The first comes from functional expression in COS, CHO, and HEK cells. In COS cells, hTrp1 and hTrp3 (6) increased CCE (Fig. 4). More recent studies show that murine Trp6 (mTrp6) also increases CCE in COS cells (G.B., X.Z., and L.B., unpublished work). However, these results by themselves did not prove that vertebrate trp genes encode CCE channels. This is because COS cells, like any other cell for that matter, have endogenous CCE channels that respond to both store depletion and agonist stimulation and because detection of functional CCE channels after transfection with a trp involves protocols that activate these endogenous channels.
The second argument for Trp(s) being part of CCE channels is that expression of hTrp1Δ34 (also TRPC1A) in CHO cells (42) and of hTrp3 in HEK 293 cells (Fig. 5) cause the appearance of nonselective Ca2+-permeable cation channels that are not detected in cells transfected with control plasmids. For Trp3, these channels appear to have a single channel conductance of 20 pS, as deduced from noise variance analysis of transmembrane currents recorded under the whole cell configuration (D.P., L.B., and S.E., unpublished work).
Unanswered by these results is the question whether Trps are pore-forming subunits of CCE channels or essential regulatory subunits that, when expressed in cells, merely “recruit” the channel proper. Notably in the case of mammalian Trps, the type of CCE channel generated by their expression is a nonselective Ca2+-permeable cation channel, leaving open the possibility that the highly Ca2+-selective channel responsible for ICRAC in macrophages and lymphocytes, may be encoded in an unrelated type of molecule. Against this argument are the results of Sinkins et al. (43) on the ion selectivities of chimeric Trps expressed in Sf9 cells. These authors found that chimera DTrp/DTrpl, composed of the N terminus plus polytransmembrane domain of Drosophila Trp and the C terminus of the Drosophila Trpl, had the ion selectivity of Trp and was insensitive to store depletion, while the reverse chimera (DTrpl/DTrp) had the ion selectivity of Trpl but had acquired Trp’s responsiveness to store depletion. It is difficult to explain how this type of result could be obtained if Trps are not the pore-forming units.
Consistent with the idea that trp genes encode channel subunits and participate as obligatory elements in CCE is the third experimental argument linking vertebrate Trps to CCE: interference with CCE by expression of trp sequences in the antisense direction (ref. 6; Fig. 6). Taken together, the data strongly indicate that CCE channels are composed of Trp subunits.
Although the subunit composition of a CCE channel is not yet known, the limited sequence similarity of some of the hydrophobic regions of Trp to transmembrane segments of voltage-gated Ca2+ channels suggests a tetrameric molecule made up of Trp subunits. Studies on glycosylation of hTrp3 (Fig. 7) and accessibility of the hemagglutinin (HA) epitope, placed in various locations of the protein, to immunostaining in nonpermeabilized cells impose additional constrains and lead us to hypothesize the subunit transmembrane topology depicted in Fig. 3B3. Two tetrameric structures made of Trp subunits are depicted in Fig. 8. The proposed multisubunit structure together with the existence of up to six nonallelic genes in vertebrate genomes offer an easy explanation for functional heterogeneity. Store depletion-activated vs. store depletion-independent CCE channels and highly Ca2+ selective vs. nonselective cation channels are differences that can easily be explained as being due to formation of different homomultimeric or heteromultimeric Trp-based channels.
CCE Channels May Be Activated by Two Distinct Signaling Mechanisms
As is the case for structural organization of CCE channels, there is only scant information available as to how or by what mechanism CCE channels are activated. Among the signaling mechanisms and pathways that have been implicated as mediating activation of CCE are: (i) slowly activating pertussis toxin-sensitive G proteins (45); (ii) small molecular weight GTP-binding proteins (17, 46, 47); (iii) cGMP (48–50); (iv) IP3 (51); (v) tyrosine phosphorylation (52); (vi) activation of cellular phosphatases (53, 54); (vii) arachidonic acid (21, 55); (viii) formation of diffusible messengers of unknown identity (56–58); (ix) direct physical interaction of the CCE channel with an element of the storage compartment, possibly the IP3 receptor itself; and (x) physical translocation of CCE channel containing intracellular vesicles to the plasma membrane. Physical coupling of IP3 receptor to CCE channels is modeled after the mechanism by which the skeletal muscle voltage-sensitive Ca2+ channel activates the sarcoplasmic reticulum Ca2+ release channel, and the translocation model is based on the mechanism by which insulin stimulates glucose uptake in peripheral tissues or that by which antidiuretic hormone via cAMP promotes incorporation of water channels into the apical surface of renal collecting duct cells and thereby increases water reabsorption.
Although it is too early to settle on any one of these mechanisms, the literature clearly suggests that more than one mechanism for regulation of CCE channels must exist, and that in some cases a single CCE channel may be under control of two activating mechanisms. The best evidence for dual regulation comes from studies on visual signal transduction in Drosophila, in which it has now been shown that the initial depolarizing response is due to the combined activation of both Trp and Trpl and that Ca2+ entering through Trp channels is necessary for adaptation to continuous light. Yet, while store depletion activates Trp, as shown upon expression in Sf9 cells (38), the initial depolarizing phase of the receptor potential, which can occur within as little as 10 ms and depends on the presence of Trp and Trpl, arises very rapidly and before any discharge of Ca2+ from stores is detectable. It is thus unlikely to be the result of the generation of a “store depletion” signal (36). Moreover, the time frame is such that it is unlikely that Trp/Trpl activation involves any diffusible messenger or a metabolic reaction such as phosphorylation. Since invertebrates capture light by the same mechanism as do vertebrates (i.e., through photoisomerization of a rhodopsin molecule, which then activates a G protein), it follows that the most likely signal that acts on CCE channels, other than store depletion, diffusible messenger, or phosphorylation, is the activated G protein, either its GTP·α complex or its βγ dimer. The extremely rapid time frame of the activation process also suggests existence of physically precoupled complexes of rhodopsin, G protein, and CCE channels (Fig. 9).
Thus, while it can be taken as an almost foregone conclusion that some CCE channels are regulated directly by a G protein, the mode or mechanism by which CCE channels are activated in a receptor-, G protein-, and IP3-independent form, such as occurs upon store depletion by treatment with thapsigargin or loading of cells with BAPTA, remains obscure, as does which form or forms of CCE are under dual regulation. Some nonselective CCE channels of the type activated by agonist in heparin-loaded macrophages (17) appear to be unresponsive to store depletion, indicating existence of channels responding to G protein only. Whether the opposite situation exists is not known. Drosophila Trp-based channels respond to both the G protein signal and the store depletion signal, as do the recently cloned mammalian Trp-based channels (Figs. 4 and 5).
Conclusion
Even though there are no definitive answers as yet to questions such as what the makeup of a CCE channel actually is or by which mechanism is it activated under which circumstances, it is clear that significant advances are rapidly being made toward achieving this goal. Determining that Trp proteins are part of CCE channels was a critical first step in this process. Knowledge about how CCE channels are regulated will then be the next step for answering the questions such as how a store knows that it is being emptied—i.e., the molecular basis for Ca2+ sensing within the stores. Given that Ca2+ entering cells through CCE is of fundamental physiological importance for processes as disparate as Gs-independent cAMP generation by type III and VIII adenylyl cyclases in the central nervous system (59, 60), the mediation of the mitogenic response of lymphocytes exposed to stimuli that activate the T-cell receptor (61, 62) and sustained secretory responses of endocrine cells, as was shown some years ago by Albert and Tashjian (63), it is to be expected that the unraveling of the mechanisms that regulate CCE will give new insights not only into CCE but also into other Ca2+-dependent processes not yet so well-defined but nevertheless important.
Acknowledgments
This research was supported in part by National Institutes of Health Grants HL45198, DK19318, and AR43411 to L.B., AR38970 to E.S., and DK41244 to M.B., a postdoctoral fellowship from the Canadian Medical Research Council to G.B., and a fellowship from the French Cancer Society to B.V.
Footnotes
Abbreviations: [Ca2+]i, cytosolic Ca2+ concentration; PLC, phospholipase C; IP3, 1,4,5-inositol trisphosphate; CCE, capacitative calcium entry; CCh, carbachol; BAPTA, bis(2-aminophenoxy)ethane-N,N,N′,N′-tetra-acetate; h, human; m, murine; HA, hemagglutinin.
References
- 1.Birnbaumer L, Campbell K P, Catterall W A, Harpold M M, Hofmann F, Horne W A, Mori Y, Schwartz A, Snutch T P, Tanabe T, Tsien R W. Neuron. 1994;13:505–506. doi: 10.1016/0896-6273(94)90021-3. [DOI] [PubMed] [Google Scholar]
- 2.Perez-Reyes E, Schneider T. Kidney Int. 1995;48:1111–1124. doi: 10.1038/ki.1995.395. [DOI] [PubMed] [Google Scholar]
- 3.Seeburg P H. Trends Neurosci. 1993;16:359–365. doi: 10.1016/0166-2236(93)90093-2. [DOI] [PubMed] [Google Scholar]
- 4.Fasolato C, Innocenti B, Pozzan T. Trends Pharmacol Sci. 1994;15:77–83. doi: 10.1016/0165-6147(94)90282-8. [DOI] [PubMed] [Google Scholar]
- 5.Striggow F, Ehrlich B E. Curr Opin Cell Biol. 1996;8:490–495. doi: 10.1016/s0955-0674(96)80025-1. [DOI] [PubMed] [Google Scholar]
- 6.Zhu X, Jiang M, Peyton M J, Boulay G, Hurst R, Stefani E, Birnbaumer L. Cell. 1996;85:661–671. doi: 10.1016/s0092-8674(00)81233-7. [DOI] [PubMed] [Google Scholar]
- 7.Smrcka A V, Hepler J R, Brown K O, Sternweis P C. Science. 1991;251:804–807. doi: 10.1126/science.1846707. [DOI] [PubMed] [Google Scholar]
- 8.Taylor S J, Chae H Z, Rhee S G, Exton J H. Nature (London) 1991;350:516–518. doi: 10.1038/350516a0. [DOI] [PubMed] [Google Scholar]
- 9.Margolis B, Rhee S G, Felder S, Mervic M, Lyall R, Levitski A, Ullrich A, Zilberstein A, Schlessinger J. Cell. 1989;57:1101–1111. doi: 10.1016/0092-8674(89)90047-0. [DOI] [PubMed] [Google Scholar]
- 10.Kim H K, Kim J W, Zilberstein A, Margolis B, Kim J G, Schlessinger J, Rhee S G. Cell. 1991;65:435–445. doi: 10.1016/0092-8674(91)90461-7. [DOI] [PubMed] [Google Scholar]
- 11.Thastrup O, Cullen P J, Drobak B K, Hanley M R, Dawson A P. Proc Natl Acad Sci USA. 1990;87:2466–2470. doi: 10.1073/pnas.87.7.2466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Kwan C Y, Takemura H, Obie J F, Thastrup O, Putney J W., Jr Am J Physiol. 1990;258:C1006–C1015. doi: 10.1152/ajpcell.1990.258.6.C1006. [DOI] [PubMed] [Google Scholar]
- 13.Putney J W, Jr, Bird G S. Endocr Rev. 1993;14:610–631. doi: 10.1210/edrv-14-5-610. [DOI] [PubMed] [Google Scholar]
- 14.Hoth M, Penner R. Nature (London) 1992;355:353–356. doi: 10.1038/355353a0. [DOI] [PubMed] [Google Scholar]
- 15.Hoth M, Penner R. J Physiol (London) 1993;465:359–386. doi: 10.1113/jphysiol.1993.sp019681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Zweifach A, Lewis R S. Proc Natl Acad Sci USA. 1993;90:6295–6299. doi: 10.1073/pnas.90.13.6295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Fasolato C, Hoth M, Matthews G, Penner R. Proc Natl Acad Sci USA. 1993;90:3068–3072. doi: 10.1073/pnas.90.7.3068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Nakamura T, Ui M. J Biol Chem. 1985;260:3584–3593. [PubMed] [Google Scholar]
- 19.Lückhoff A, Clapham D E. Biophys J. 1994;67:177–182. doi: 10.1016/S0006-3495(94)80467-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ufret-Vincenty C A, Short A D, Alfonso A, Gill D L. J Biol Chem. 1995;270:26790–26793. doi: 10.1074/jbc.270.45.26790. [DOI] [PubMed] [Google Scholar]
- 21.Shuttleworth T J. J Biol Chem. 1996;271:21720–21725. doi: 10.1074/jbc.271.36.21720. [DOI] [PubMed] [Google Scholar]
- 22.Clementi E, Scheer H, Zacchetti D, Fasolato C, Pozzan T, Meldolesi J. J Biol Chem. 1992;267:2164–2172. [PubMed] [Google Scholar]
- 23.Kass G E N, Chow S C, Gahm A, Webb D-L, Berggren P-O, Llopis J, Orrenius S. Biochim Biophys Acta. 1993;1223:226–233. doi: 10.1016/0167-4889(94)90230-5. [DOI] [PubMed] [Google Scholar]
- 24.Montero M, Garcia-Sancho J, Alvarez J. J Biol Chem. 1994;269:29451–29456. [PubMed] [Google Scholar]
- 25.Byron K, Taylor C W. J Physiol (London) 1995;485:455–468. doi: 10.1113/jphysiol.1995.sp020742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Clapham D E. Cell. 1995;80:259–268. doi: 10.1016/0092-8674(95)90408-5. [DOI] [PubMed] [Google Scholar]
- 27.Bootman M D, Cheek T R, Moreton R B, Bennet D L, Berridge M J. J Biol Chem. 1994;269:24783–24791. [PubMed] [Google Scholar]
- 28.Devary O, Heichal O, Blumenfeld A, Cassel D, Suss E, Barash S, Rubinstein C T, Minke B, Selinger Z. Proc Natl Acad Sci USA. 1987;84:6939–6943. doi: 10.1073/pnas.84.19.6939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Selinger Z, Minke B. Cold Spring Harbor Symp Quant Biol. 1988;53:333–341. doi: 10.1101/sqb.1988.053.01.040. [DOI] [PubMed] [Google Scholar]
- 30.Bloomquist B T, Shortridge R D, Schneuwly S, Perdew M, Montell C, Steller H, Rubin G, Pak W L. Cell. 1988;54:723–733. doi: 10.1016/s0092-8674(88)80017-5. [DOI] [PubMed] [Google Scholar]
- 31.Cosens D J, Manning A. Nature (London) 1969;224:285–287. doi: 10.1038/224285a0. [DOI] [PubMed] [Google Scholar]
- 32.Hardie R C, Minke B. Neuron. 1992;8:643–651. doi: 10.1016/0896-6273(92)90086-s. [DOI] [PubMed] [Google Scholar]
- 33.Montell C, Rubin G M. Neuron. 1989;2:1313–1323. doi: 10.1016/0896-6273(89)90069-x. [DOI] [PubMed] [Google Scholar]
- 34.Phillips A M, Bull A, Kelly L E. Neuron. 1992;8:631–642. doi: 10.1016/0896-6273(92)90085-r. [DOI] [PubMed] [Google Scholar]
- 35.Hardie R C, Minke B. Trends Neurosci. 1993;9:371–376. doi: 10.1016/0166-2236(93)90095-4. [DOI] [PubMed] [Google Scholar]
- 36.Niemeyer B, Suzuki E, Scott K, Jalinik K, Zuker C S. Cell. 1996;83:651–659. doi: 10.1016/s0092-8674(00)81232-5. [DOI] [PubMed] [Google Scholar]
- 37.Ranganthan R, Bakscai B J, Tsien R Y, Zuker C S. Cell. 1994;83:837–848. doi: 10.1016/0896-6273(94)90250-x. [DOI] [PubMed] [Google Scholar]
- 38.Vaca L, Sinkins W G, Hu Y, Kunze D, Schilling W P. Am J Physiol. 1994;267:C1501–C1505. doi: 10.1152/ajpcell.1994.267.5.C1501. [DOI] [PubMed] [Google Scholar]
- 39.Hu Y, Vaca L, Zhu X, Birnbaumer L, Kunze D, Schilling W P. Biochem Biophys Res Commun. 1994;132:346–354. doi: 10.1006/bbrc.1994.1808. [DOI] [PubMed] [Google Scholar]
- 40.Wes P D, Chevesich J, Jeromin A, Rosenberg C, Stetten G, Montell C. Proc Natl Acad Sci USA. 1995;92:9652–9656. doi: 10.1073/pnas.92.21.9652. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Zhu X, Chu P B, Peyton M, Birnbaumer L. FEBS Lett. 1995;373:193–198. doi: 10.1016/0014-5793(95)01038-g. [DOI] [PubMed] [Google Scholar]
- 42.Zitt C, Zobel A, Obukhov A G, Harteneck C, Kalkbrenner F, Lückhoff A, Schultz G. Neuron. 1996;16:1189–1196. doi: 10.1016/s0896-6273(00)80145-2. [DOI] [PubMed] [Google Scholar]
- 43.Sinkins W G, Vaca L, Hu Y, Kunze D L, Schilling W P. J Biol Chem. 1996;271:2955–2960. doi: 10.1074/jbc.271.6.2955. [DOI] [PubMed] [Google Scholar]
- 44.Innamorati G, Sadeghi H, Birnbaumer M. Mol Pharmacol. 1996;50:467–473. [PubMed] [Google Scholar]
- 45.Berven L A, Hughes B P, Barritt G J. Biochem J. 1994;299:399–407. doi: 10.1042/bj2990399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Bird G S J, Putney J W. J Biol Chem. 1993;268:21486–21488. [PubMed] [Google Scholar]
- 47.Jaconi M E, Lew D P, Monod A, Krause K-H. J Biol Chem. 1993;268:26075–26078. [PubMed] [Google Scholar]
- 48.Bahnson T D, Pandol S J, Dionne V E. J Biol Chem. 1993;268:10808–10812. [PubMed] [Google Scholar]
- 49.Gukovskaya A, Pandol S J. Am J Physiol. 1994;266:G350–G356. doi: 10.1152/ajpgi.1994.266.3.G350. [DOI] [PubMed] [Google Scholar]
- 50.Gilon P, Obie J F, Bian X, Bird G S, Putney J W., Jr Biochem J. 1995;311:649–656. doi: 10.1042/bj3110649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Dong Y, Kunze D, Vaca L, Schilling W P. Am J Physiol. 1995;269:C1332–C1339. doi: 10.1152/ajpcell.1995.269.5.C1332. [DOI] [PubMed] [Google Scholar]
- 52.Sage S O, Sargeant P, Jenner S, Farndale R W. Trends Pharmacol Sci. 1994;15:282. doi: 10.1016/0165-6147(94)90007-8. [DOI] [PubMed] [Google Scholar]
- 53.Sargeant P, Farndale R W, Sage S O. J Biol Chem. 1993;268:18151–18156. [PubMed] [Google Scholar]
- 54.Koike Y, Ozaki Y, Qi R, Satoh K, Kurota K, Yatomi Y, Kume S. Cell Calcium. 1994;15:381–390. doi: 10.1016/0143-4160(94)90013-2. [DOI] [PubMed] [Google Scholar]
- 55.Rzigalinski B A, Blackmore P F, Rosenthal M D. Biochim Biophys Acta. 1996;1299:342–352. doi: 10.1016/0005-2760(95)00224-3. [DOI] [PubMed] [Google Scholar]
- 56.Parekh A B, Terlau H, Stuehmer W. Nature (London) 1993;364:814–815. doi: 10.1038/364814a0. [DOI] [PubMed] [Google Scholar]
- 57.Randriamampita C, Tsien R Y. Nature (London) 1993;364:809–814. doi: 10.1038/364809a0. [DOI] [PubMed] [Google Scholar]
- 58.Randriamampita C, Tsien R Y. J Biol Chem. 1994;269:29–32. doi: 10.1074/jbc.270.1.29. [DOI] [PubMed] [Google Scholar]
- 59.Chiono M, Mahey R, Tate G, Cooper D M F. J Biol Chem. 1995;270:1149–1155. doi: 10.1074/jbc.270.3.1149. [DOI] [PubMed] [Google Scholar]
- 60.Fagan K A, Mahey R, Cooper D M F. J Biol Chem. 1996;271:12438–12444. doi: 10.1074/jbc.271.21.12438. [DOI] [PubMed] [Google Scholar]
- 61.Lewis R S, Cahalan M D. Cell Regul. 1989;1:99–112. doi: 10.1091/mbc.1.1.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Gardner P, Alcover A, Kuno M, Moigeon P, Weyand C M, Goronzy J, Reinherz E L. J Biol Chem. 1989;269:1058–1076. [PubMed] [Google Scholar]
- 63.Albert P R, Tashjian A H. J Biol Chem. 1984;259:5827–5832. [PubMed] [Google Scholar]